The patterns of RET proto-oncogene expression in mouse, rat, and chicken and the anomalies observed in targeted RET mutants suggest that RET plays a major role in development of mouse enteric nervous system and in kidney organogenesis. Here, we report on in situ hybridization studies describing the
Expression of proto-oncogenes in xenografts of human renal cell carcinomas
β Scribed by Karthaus, H. F. M. ;Bussemakers, M. J. G. ;Schalken, J. A. ;Kurth, K. H. ;Feitz, W. F. J. ;Debruyne, F. M. J. ;Bloemers, H. P. J. ;Van de Ven, W. J. M.
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 527 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
β¦ Synopsis
In a recent paper, we described the expression pattern of proto-oncogenes in primary human renal cell carcinoma [12]. To test the possibility of using xenografts as a useful alternative for such studies, we analyzed xenografts of a number of human renal cell carcinomas in nu/nu mice. Xenografts included RC2, RC14, RC21, RC43 and NC65. Northern blot analysis indicated that c-Ras was expressed in all these xenografts. The identity of the ras transcripts in the individual xenografts was further specified as c-Ha-ras, c-Ki-ras or N-ras. Expression of c-myc and the p53 gene was also found in a number of these tumors. Only RC21 failed to express the c-myc or the p53 gene. In all xenografts, a 3.0 kb c-fes/fps mRNA was present. In RC2, RC14, RC21 and RC43, low levels of the 4.8 kb ab 1 transcript were detectable. Transcripts of myb and sis could not be detected in any of the xenografts. The results indicated that the expression pattern of a variety of proto-oncogenes in xenografts of human renal cell carcinomas was similar to that in the primary tumors.
π SIMILAR VOLUMES
The over-expression of the proto-oncogene HER-2 (c-erbB-2/ neu) in ovarian, endometrial and mammary carcinoma is an important indicator for poor prognosis. We have previously shown in 3 out of 4 ovarian carcinoma cell lines an interferongamma (IFN-+mediated reduction in HER-2 specific protein and RN
Cyclin-D1 over-expression represents one of several common alterations in the G 1 -S transition associated with malignancies. Conclusive evidences indicate that cyclin D1 is a proto-oncogene and the gene is amplified or rearranged in different tumour types. Since very little is known about aberratio